About Bain Capital Life Sciences

Bain Capital Life Sciences invests in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe, with a focus on companies that both drive medical innovation across the value chain and enable that innovation to improve the lives of patients with unmet medical needs. The differentiated skillset of Bain Capital Life Sciences team enables it to deliver targeted capital and value-added strategic support to companies around critical phases of growth and inflections in value.

Since 1984, Bain Capital has employed a strategic and analytical approach to identify attractive investment opportunities and partner with management teams to transform and improve their businesses. During this time, Bain Capital has developed global reach, deep expertise, and a proven track record in the life sciences industries across private equity, public equity, credit, venture capital, and real estate.

By the Numbers

$03B

ASSETS UNDER MANAGEMENT

045

INVESTMENTS

Globally, across diagnostics & life sciences tools, medical devices, and biotechnology & pharmaceuticals

061

TRIALS FUNDED

To help improve the lives of patients with unmet medical needs

029

BOARD POSITIONS

from the start of investment

All figures as of March 31, 2021

Bain Capital Healthcare

We have built one of the largest and deepest healthcare investing teams in the world. Click here to read more about the breadth and legacy of our efforts.